Five judges on the European Union’s top court in Luxembourg are set to rule on the legality of France’s ban on hemp-derived CBD – and potentially upend the future of Europe’s hemp industry in the process. Thursday’s ruling from the Court of Justice of the European Union on the so-called Kanavape case is one of […]
Read MoreMonica Raymunt
Report: Chinese hemp company lands $75 million investment from pharma giant
China’s biotech and pharma giant Tasly Holding Group has announced a 500 million yuan ($75.6 million) investment into biotech company Puyuan Miaosheng Group’s industrial hemp subsidiary. The investment will be used to develop Yunnan Maye Biotech’s operations in hemp farming, foods and beverages, pet food, new tobacco products and vaporizers, and biopharmaceutical products in five […]
Read MoreHemp group eyes Chinese, EU markets after securing USDA funding for overseas marketing
The National Industrial Hemp Council has set its sights on Asian and European hemp markets after it says it was allocated $200,000 from the U.S. Department of Agriculture to promote U.S. hemp products abroad.
Read MoreGerman retailer Aldi rolls out private-label hemp line in UK
Aldi UK, the British arm of the German supermarket chain, has launched a house line of hempseed oil skincare products, joining the ranks of grocers carrying hemp and incorporating it in store-brand products.
Read MoreItalian economists: High-CBD hemp flower cut into illicit MJ market, hurt organized crime
The availability of hemp flower containing up to 0.6% THC in Italy led some marijuana users to abandon their illicit products, costing criminal networks tens of millions, a trio of economists has found. The researchers’ findings, published last year in the European Economic Review, suggest Italy’s criminal organizations lost tens of millions of euros after […]
Read MoreReport: New Zealand health agency cracks down on illegal CBD sales
Authorities in New Zealand have threatened two hemp farmers with a $100,000 fine and loss of hemp license for selling products containing cannabidiol, which is permitted only in prescription medications in the country.
Read MoreCBD for seniors: Best practices for winning over an emerging market
As the U.S. population ages, businesses in the health and wellness industry are starting to recognize older consumers as a new and emerging market.
Read More2020 survival strategies: Why Elixinol cut half its workforce, halted production and refocused for future growth
Hemp-derived CBD supplement maker Elixinol shed half of its global workforce and shuttered production lines in the first half of this year in response to market decline stemming from the global COVID-19 pandemic. Now the Australian company is looking to leverage a leaner operation and focus on its core CBD brands for future success. Talking […]
Read MoreItaly suspends decree that added CBD preparations to narcotics law
Italy’s Health Ministry has backtracked on its decision to add ingestible, hemp-derived CBD formulas to a list of medicines in its narcotics law, issuing a decree to suspend the controversial change one day before it was due to take effect.
Read MoreEuropean Parliament votes to add 0.3% THC limit for hemp to EU farm policy overhaul
The European Parliament has voted to raise the THC limit for industrial hemp from 0.2% to 0.3% and allow hemp and hemp-derived products to be subject to European Union marketing standards.
Read MoreSelf-governing British island is getting into the CBD business
The Isle of Man, a self-governing British dependency located between Ireland and England, has announced plans to create an export-only sector for hemp and cannabis products.
Read MoreIn Italy, a change on CBD medicine classification stokes confusion in hemp industry
Italy’s Health Ministry has added cannabidiol compositions for oral consumption to a table of medicines, paving the way for GW Pharmaceuticals; epilepsy drug Epidiolex to hit the market there.
Read More